Table 1 General clinical data of all the patients
Characters | Test group (n = 208) | Control group (n = 204) |
|---|---|---|
Age group, years | ||
< 60 | 96 (46.2%) | 95 (46.6%) |
≥ 60 | 112 (53.8%) | 109 (53.4%) |
Gender | ||
Male | 135 (64.9%) | 124 (60.8%) |
Female | 73 (35.1%) | 80 (39.2%) |
Smoking history | ||
Never smoker | 29 (13.9%) | 23 (11.3%) |
Former smoker | 81 (39.0%) | 88 (43.1%) |
Current smoker | 98 (47.1%) | 93 (45.6%) |
KPS score | ||
60–75 | 80 (38.5%) | 84 (41.2%) |
> 75 | 128 (61.5%) | 120 (58.8%) |
Metastasis | ||
Yes | 99 (47.6%) | 96 (47.1%) |
No | 109 (52.4%) | 108 (52.9%) |
Disease staging | ||
I-II | 113 (54.3%) | 106 (52.0%) |
III-IV | 95 (45.7%) | 98 (48.0%) |
Classification | ||
SCLC | 44 (21.2%) | 40 (19.6%) |
NSCLC | 164 (78.8%) | 164 (80.4%) |
NSCLC type | ||
LADC | 109 (66.5%) | 108 (65.9%) |
LSCC | 55 (33.5%) | 56 (34.1%) |